Sun, Aug 18 1:16am

Compare IDXG



Interpace Diagnostics Group Inc [IDXG]
$0.76 0.01 (1.33%)

IDXG Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 30 Million
IDXG Description

Interpace Diagnostics Group Inc is a United States-based integrated commercial and bioinformatics company. It is engaged in developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management. The company has four commercialized molecular tests, PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next-generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay, and RespriDX for assessing metastatic versus primary lung cancer tumors. The company's customers consist of physicians, hospitals, and clinics.


Visit Website

IDXG Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Mon, May 13, 2019
Latest Earnings Tue, Aug 13, 2019 (5 days ago) -8.43%

IDXG Dividend

Yield --
Ex-Date --
Pay Date --
History --

IDXG Charts

$0.68
1 Year
$1.73
Jun 6, 2019
Sep 19, 2018



Symbol Price Day % YTD %
IDXG $0.76 1.33% -16.48%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy